Chief Executive Officer (Interim)
Neurodegeneration Initiative (Ni)
AeroLeads people directory · profile
Jessamy Baird Mbe Email & Phone Number
Chief Executive Officer (interim)
at
Neurodegeneration Initiative (NI)
LinkedIn matched
✓ Verified August 2026
3 data sources
Profile completeness 86%
Current company
Neurodegeneration Initiative (NI)
Role
Chief Executive Officer (interim)
Location
Reading, England, United Kingdom
Who is Jessamy Baird Mbe? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Jessamy Baird Mbe is listed as Chief Executive Officer (interim) at Neurodegeneration Initiative (NI), based in Reading, England, United Kingdom. AeroLeads shows a matched LinkedIn profile for Jessamy Baird Mbe.
Jessamy Baird Mbe previously worked as Healthcare and Life Sciences leader at Freelance and General Manager, General Medicines UKIE at Sanofi. Jessamy Baird Mbe studied at University Of Aberdeen.
Profile bio
About Jessamy Baird Mbe
I am passionate about bringing about change in the organisations I work in for the benefit of the people and patients we serve. Diversity, inclusion, and sustainability are at the heart of my priorities to unleash our people’s potential, and I’m a champion of individual and team development for long-term success. I have been working in the healthcare for nearly 30 years within academia, the pharmaceutical industry, and the NHS. The ability to make a positive impact on people's lives is what keeps me focused and inspired to pursue our mission every single day. I welcome you to follow my page and engage with me on new approaches to leadership, management, and the most pressing issues facing us in the healthcare industry across the UK & Ireland today.
Current workplace
Jessamy Baird Mbe's current company
Company context helps verify the profile and gives searchers a useful next step.
Neurodegeneration Initiative (Ni)
12 roles
Jessamy Baird Mbe work experience
A career timeline built from the work history available for this profile.
Healthcare And Life Sciences Leader
Current
Freelance
Jun 2024 - Present
General Manager, General Medicines Ukie
May 2020 - Jun 2024
Director Of Market Access
Feb 2015 - May 2020
Jun 2023 - Apr 2024
Non-Executive Adviser
Nhs North Hampshire Ccg
Dec 2017 - Mar 2020
Jan 2014 - Oct 2017
Director, Market Access Strategy, Ace (Australia, Canada, Eu) - Oncology
Regional (ACE) Director to support the market access strategy for Australia, Canada, Europe, and ensure patients are able to access Lilly Medicines. Working from early phase through to end of lifecycle, providing strategic leadership across functions (medical, marketing, health outcomes, corporate affairs), health policy insight, input to strategic planning and driving internal capability in price, reimbursement and market access.
Sep 2012 - Dec 2014
Executive Director, Director Of Health Technology And Outcomes
Southern Health Nhs Foundation Trust
Reporting to the Chief Executive Officer, this fixed-term Board Executive role encompassed the Directorates of Technology, Health Informatics, Research and Outcomes development at Southern Health NHS Foundation Trust, an NHS Mental Health and Community Care Foundation Trust covering Hampshire.
Apr 2011 - Sep 2012
Hta Director; Europe, Australia, Canada, Japan
Director responsible for the practical implementation of health economics methodological expertise externally, both through HTA dossiers but also via local healthcare decision maker activities to develop the value proposition of medicines, working cross-functionally with marketing and medical colleagues. Leadership role on reimbursement and access strategies, extending from the very early phase of development of the molecule to influencing the external environment for HTA and pricing across the EU, Australia and Japan in order to provide optimal access for patients to Lilly’s future medicines.
Jan 2010 - Mar 2011
Director Of Hta And Health Outcomes, Lilly Uk
Director responsible for HTA submissions to NICE, SMC, AWMSG, Republic of Ireland and other Regional HTA bodies, responsible for evolving the HTA strategy with the UK and global organisation in terms of positioning a product for optimal patient use and cost-effective use within NHS systems. Led on new Product Planning and Pricing for the UK, influencing the research and clinical evidence being developed for each medicine. Leadership role for the corporate affairs input, as member of the ABPI, to HTA policy and economic evaluation methodologies in the UK and within the EU.
Jan 2007 - Jan 2010
Non-Executive Director (Lay Adviser)
Non-Executive Director (Lay Adviser) for an NHS Trust Board NHS Hampshire Community Health Care, Hampshire
May 2008 - Mar 2011
2 education records
Jessamy Baird Mbe education
Education record
University Of Aberdeen
Education record
Westonbirt
FAQ
Frequently asked questions about Jessamy Baird Mbe
Quick answers generated from the profile data available on this page.
What company does Jessamy Baird Mbe work for?
Jessamy Baird Mbe works for Neurodegeneration Initiative (NI).
What is Jessamy Baird Mbe's role at Neurodegeneration Initiative (NI)?
Jessamy Baird Mbe is listed as Chief Executive Officer (interim) at Neurodegeneration Initiative (NI).
Where is Jessamy Baird Mbe based?
Jessamy Baird Mbe is based in Reading, England, United Kingdom while working with Neurodegeneration Initiative (NI).
What companies has Jessamy Baird Mbe worked for?
Jessamy Baird Mbe has worked for Neurodegeneration Initiative (Ni), Freelance, Sanofi, The Association Of The British Pharmaceutical Industry (Abpi), and Nhs North Hampshire Ccg.
How can I contact Jessamy Baird Mbe?
You can use AeroLeads to view verified contact signals for Jessamy Baird Mbe at Neurodegeneration Initiative (NI), including work email, phone, and LinkedIn data when available.
What schools did Jessamy Baird Mbe attend?
Jessamy Baird Mbe studied at University Of Aberdeen.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial